Justin J. McAnear
Net Worth

Last updated:

What is Justin J. McAnear net worth?

The estimated net worth of Mr. Justin J. McAnear is at least $30,187,939 as of 22 Aug 2024. He owns shares worth $1,924,943 as insider, has earned $26,612,996 from insider trading and has received compensation worth at least $1,650,000 in 10x Genomics, Inc..

What is the salary of Justin J. McAnear?

Mr. Justin J. McAnear salary is $330,000 per year as Chief Financial Officer in 10x Genomics, Inc..

How old is Justin J. McAnear?

Mr. Justin J. McAnear is 49 years old, born in 1976.

What stocks does Justin J. McAnear currently own?

As insider, Mr. Justin J. McAnear owns shares in one company:

Company Title Shares Price per share Total value
10x Genomics, Inc. (TXG) Chief Financial Officer 143,242 $13.44 $1,924,943

What does 10x Genomics, Inc. do?

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

TXG logo
TXG
10x Genomics, Inc.
$13.44

Justin J. McAnear insider trading

10x Genomics, Inc.

Mr. Justin J. McAnear has made 50 insider trades between 2020-2024, according to the Form 4 filled with the SEC. Most recently he sold 2,961 units of TXG stock worth $66,711 on 22 Aug 2024.

The largest trade he's ever made was exercising 19,841 units of TXG stock on 23 Dec 2020. As of 22 Aug 2024 he still owns at least 143,242 units of TXG stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Class A Common Stock 2,961 $22.53 $66,711
Sale
Class A Common Stock 2,936 $24.3 $71,357
Sale
Class A Common Stock 1,865 $46.34 $86,432
Sale
Class A Common Stock 1,679 $43.34 $72,763
Sale
Class A Common Stock 1,678 $45.78 $76,821
Sale
Class A Common Stock 441 $55.06 $24,283
Sale
Class A Common Stock 565 $55.06 $31,111
Sale
Class A Common Stock 465 $55.06 $25,604
Sale
Class A Common Stock 194 $55.07 $10,684
Sale
Class A Common Stock 1,245 $47.75 $59,452
Sale
Class A Common Stock 686 $34.07 $23,369
Sale
Class A Common Stock 652 $34.07 $22,212
Sale
Class A Common Stock 288 $34.07 $9,811
Sale
Class A Common Stock 987 $35.19 $34,734
Sale
Class A Common Stock 967 $48.76 $47,155
Purchase
Class A Common Stock 158 $40.49 $6,397
Sale
Class A Common Stock 288 $78.6 $22,637
Sale
Class A Common Stock 10,000 $147.05 $1,470,510
Option
Stock Option (right to buy) 10,000 $5.04 $50,400
Option
Class A Common Stock 10,000 $5.04 $50,400
Option
Stock Option (right to buy) 10,000 $5.04 $50,400
Option
Class A Common Stock 10,000 $5.04 $50,400
Sale
Class A Common Stock 10,000 $150.08 $1,500,770
Sale
Class A Common Stock 281 $148.38 $41,695
Option
Class A Common Stock 10,000 $5.04 $50,400
Sale
Class A Common Stock 10,000 $163 $1,629,980
Option
Stock Option (right to buy) 10,000 $5.04 $50,400
Option
Class A Common Stock 10,000 $5.04 $50,400
Sale
Class A Common Stock 10,000 $143.28 $1,432,820
Option
Stock Option (right to buy) 10,000 $5.04 $50,400
Option
Class A Common Stock 10,000 $5.04 $50,400
Option
Stock Option (right to buy) 10,000 $5.04 $50,400
Sale
Class A Common Stock 10,000 $176.9 $1,769,000
Sale
Class A Common Stock 270 $161.85 $43,699
Option
Stock Option (right to buy) 10,000 $5.04 $50,400
Sale
Class A Common Stock 10,000 $181.32 $1,813,170
Sale
Class A Common Stock 10,000 $181.32 $1,813,170
Option
Class A Common Stock 10,000 $5.04 $50,400
Option
Class A Common Stock 10,000 N/A N/A
Sale
Class A Common Stock 10,000 N/A N/A
Option
Stock Option (right to buy) 10,000 N/A N/A
Sale
Class A Common Stock 10,000 $176.04 $1,760,420
Option
Class A Common Stock 10,000 $5.04 $50,400
Sale
Class A Common Stock 10,000 $176.04 $1,760,420
Sale
Class A Common Stock 10,000 $108.64 $1,086,360
Option
Stock Option (right to buy) 10,000 $5.04 $50,400
Sale
Class A Common Stock 281 $162.66 $45,707
Sale
Class A Common Stock 10,000 $192.98 $1,929,770
Option
Class A Common Stock 10,000 N/A N/A
Option
Stock Option (right to buy) 10,000 N/A N/A
Sale
Class A Common Stock 10,000 N/A N/A
Option
Class A Common Stock 10,000 $5.04 $50,400
Sale
Class A Common Stock 10,000 $183.32 $1,833,220
Sale
Class A Common Stock 10,000 $183.32 $1,833,220
Option
Stock Option (right to buy) 10,000 $5.04 $50,400
Option
Class A Common Stock 9,583 N/A N/A
Option
Stock Option (right to buy) 9,583 $11.48 $110,013
Option
Stock Option (right to buy) 10,000 $5.04 $50,400
Sale
Class A Common Stock 10,000 $99.53 $995,310
Option
Class A Common Stock 10,000 $5.04 $50,400
Sale
Class A Common Stock 10,000 $176.44 $1,764,430
Option
Stock Option (right to buy) 10,000 N/A N/A
Option
Class A Common Stock 10,000 N/A N/A
Sale
Class A Common Stock 10,000 N/A N/A
Option
Stock Option (right to buy) 10,000 N/A N/A
Option
Class A Common Stock 10,000 N/A N/A
Sale
Class A Common Stock 10,000 $140.42 $1,404,190
Sale
Class A Common Stock 10,000 N/A N/A
Option
Class A Common Stock 19,841 N/A N/A
Option
Stock Option (right to buy) 19,841 N/A N/A
Sale
Class A Common Stock 10,000 N/A N/A
Option
Stock Option (right to buy) 10,000 N/A N/A
Option
Class A Common Stock 10,000 N/A N/A
Sale
Class A Common Stock 2,900 N/A N/A
Option
Class A Common Stock 2,900 N/A N/A
Option
Stock Option (right to buy) 2,900 N/A N/A
Sale
Class A Common Stock 7,100 N/A N/A
Option
Stock Option (right to buy) 7,100 N/A N/A
Option
Class A Common Stock 7,100 N/A N/A
Sale
Class A Common Stock 10,000 N/A N/A
Option
Stock Option (right to buy) 10,000 N/A N/A
Option
Class A Common Stock 10,000 N/A N/A
Option
Class A Common Stock 10,000 N/A N/A
Sale
Class A Common Stock 10,000 N/A N/A
Option
Stock Option (right to buy) 10,000 N/A N/A
Sale
Class A Common Stock 10,000 N/A N/A
Option
Class A Common Stock 10,000 N/A N/A
Option
Stock Option (right to buy) 10,000 N/A N/A
Option
Stock Option (right to buy) 10,000 N/A N/A
Sale
Class A Common Stock 10,000 N/A N/A
Option
Class A Common Stock 10,000 N/A N/A
Option
Class A Common Stock 10,000 N/A N/A
Sale
Class A Common Stock 10,000 N/A N/A
Option
Stock Option (right to buy) 10,000 N/A N/A
Option
Class A Common Stock 10,000 N/A N/A
Sale
Class A Common Stock 10,000 N/A N/A
Option
Stock Option (right to buy) 10,000 N/A N/A
Sale
Class A Common Stock 10,000 N/A N/A
Option
Stock Option (right to buy) 10,000 N/A N/A
Option
Class A Common Stock 10,000 N/A N/A
Option
Stock Option (right to buy) 10,000 N/A N/A
Option
Class A Common Stock 10,000 N/A N/A
Sale
Class A Common Stock 10,000 N/A N/A

10x Genomics key executives

10x Genomics, Inc. executives and other stock owners filed with the SEC: